2025 annual financial data
Stoke Therapeutics 2025 Operating margin
Stoke Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -11.16%.
Operating income was -20,590,000 USD and net income was -6,885,000 USD.
Operating cash flow was 45,585,000 USD.
Get free Stoke Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 184,420,000 USD
- Operating income
- -20,590,000 USD
- Net income
- -6,885,000 USD
- Operating cash flow
- 45,585,000 USD